Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT06924970 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 56 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Agios Pharmaceuticals, Inc. |
| Last Updated on CT.gov | March 30, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT06924970 is currently recruiting participants. This clinical trial study for sickle cell disease is actively seeking new participants at 5 locations across the United States. The study is sponsored by Agios Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06924970 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06924970 was last updated 2 weeks ago (March 30, 2026). HelloStudys verifies this status automatically.